Overall, Morgan Stanley is positive on medical technology’s improving fundamentals. But it notes that expectations for the sector are elevated, which sets it up to disappoint.
Financial advisors who want to add this healthcare subsector to client portfolios should think of medical device ETFs as a hybrid—they have the defensive characteristics of healthcare and the growth aspects of technology.
As such, Dhanraj says, they can be considered an “all-weather” play.